Preventing Developmental Origins of Cardiovascular Disease: Hydrogen Sulfide as a Potential Target?

被引:26
|
作者
Hsu, Chien-Ning [1 ,2 ]
Tain, You-Lin [3 ,4 ,5 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung 833, Taiwan
[2] Kaohsiung Med Univ, Sch Pharm, Kaohsiung 807, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung 833, Taiwan
[4] Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung 833, Taiwan
关键词
hydrogen sulfide; cardiovascular disease; hypertension; atherosclerosis; cysteine; developmental origins of health and disease (DOHaD); N-acetylcysteine; NITRIC-OXIDE SYNTHASE; DIABETES-ACCELERATED ATHEROSCLEROSIS; PLASMA ASYMMETRIC DIMETHYLARGININE; LOWERS BLOOD-PRESSURE; HIGH-FAT DIET; OXIDATIVE STRESS; PROGRAMMED HYPERTENSION; ENDOTHELIAL DYSFUNCTION; N-ACETYLCYSTEINE; RESVERATROL PREVENTS;
D O I
10.3390/antiox10020247
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cardiovascular system can be programmed by a diversity of early-life insults, leading to cardiovascular disease (CVD) in adulthood. This notion is now termed developmental origins of health and disease (DOHaD). Emerging evidence indicates hydrogen sulfide (H2S), a crucial regulator of cardiovascular homeostasis, plays a pathogenetic role in CVD of developmental origins. Conversely, early H2S-based interventions have proved beneficial in preventing adult-onset CVD in animal studies via reversing programming processes by so-called reprogramming. The focus of this review will first summarize the current knowledge on H2S implicated in cardiovascular programming. This will be followed by supporting evidence for the links between H2S signaling and underlying mechanisms of cardiovascular programming, such as oxidative stress, nitric oxide deficiency, dysregulated nutrient-sensing signals, activation of the renin-angiotensin system, and gut microbiota dysbiosis. It will also provide an overview from animal models regarding how H2S-based reprogramming interventions, such as precursors of H2S and H2S donors, may prevent CVD of developmental origins. A better understanding of cardiovascular programming and recent advances in H2S-based interventions might provide the answers to bring down the global burden of CVD.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 50 条
  • [21] Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease
    Bechelli, Clemence
    Macabrey, Diane
    Deglise, Sebastien
    Allagnat, Florent
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [22] Developmental origins of cardiovascular disease, type 2 diabetes and obesity in humans
    Fall, CHD
    EARLY LIFE ORIGINS OF HEALTH AND DISEASE, 2006, 573 : 8 - 28
  • [23] Developmental origins of health and disease: current knowledge and potential mechanisms
    Hoffman, Daniel J.
    Reynolds, Rebecca M.
    Hardy, Daniel B.
    NUTRITION REVIEWS, 2017, 75 (12) : 951 - 970
  • [24] JCL Roundtable: Is inflammation a future target in preventing arteriosclerotic cardiovascular disease
    Brown, W. Virgil
    Remaley, Alan T.
    Ridker, Paul M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) : 119 - 128
  • [25] CARDIOVASCULAR ACTIONS OF HYDROGEN SULFIDE
    Lefer, David
    FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 : S9 - S9
  • [26] Preventing Cardiovascular Disease
    DiNicolantonio, James J.
    O'Keefe, James H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 58 (05) : 463 - 463
  • [27] Developmental origins of accelerated cardiovascular aging
    Kovtun, Olga
    Tsyvian, Pavel
    INTERNATIONAL CONFERENCE LONGEVITY INTERVENTIONS 2020 (ICLI 2020), 2020, 22
  • [28] Developmental Origins of Health and Disease: The Role of Human Milk in Preventing Disease in the 21st Century
    Geddes, Donna T.
    Prescott, Susan L.
    JOURNAL OF HUMAN LACTATION, 2013, 29 (02) : 123 - 127
  • [29] Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies
    Quiles-Jimenez, Ana
    Dahl, Tuva B.
    Bjoras, Magnar
    Alseth, Ingrun
    Halvorsen, Bente
    Gregersen, Ida
    STROKE, 2022, 53 (06) : 2114 - 2122
  • [30] CARD9 as a potential target in cardiovascular disease
    Peterson, Matthew R.
    Haller, Samantha E.
    Ren, Jun
    Nair, Sreejayan
    He, Guanglong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3799 - 3804